Lorcaserin Extended-Release Tablets and Sarilumab Subcutaneous
Determining the interaction of Lorcaserin Extended-Release Tablets and Sarilumab Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: lorcaserin
Brand name: Belviq, Belviq XR
Synonyms: Lorcaserin
Generic Name: sarilumab
Brand name: Kevzara, Kevzara Pre-filled Pen
Synonyms: Sarilumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Lorcaserin Extended-Release Tablets-Sarna Hc Topical application
- Lorcaserin Extended-Release Tablets-Sarnol-HC
- Lorcaserin Extended-Release Tablets-Sarnol-HC Maximum Strength
- Lorcaserin Extended-Release Tablets-SAStid
- Lorcaserin Extended-Release Tablets-Sastid Soap Topical
- Lorcaserin Extended-Release Tablets-SAStid Topical
- Sarilumab Subcutaneous-Lorcaserin Hydrochloride
- Sarilumab Subcutaneous-Lorcaserin Tablets
- Sarilumab Subcutaneous-Lorcet
- Sarilumab Subcutaneous-Lorcet Plus
- Sarilumab Subcutaneous-Lorcet Tablets
- Sarilumab Subcutaneous-Lorlatinib